TEK and glaucoma: Loss of function variants in TEK, or its trabecular meshwork (TM)-expressed ligand ANGPT1 cause primary congenital glaucoma (PCG), a severe form of pediatric glaucoma, in humans and mice and are associated with increased risk of primary open angle glaucoma (POAG) in adults [9–11].